Keynote Speakers

Leonie Pihama

Te Ātiawa, , Waikato, Taranaki
Te Kōtahi Institute, University of Waikato, Aotearoa (New Zealand)

Leonie is a mother of six and grandmother of six. She is Professor of Māori and Indigenous Research at  Tū Tama Wāhine o Taranaki and Māori and Indigenous Analysis Ltd. She was awarded ‘Te Tohu Pae Tawhiti’ (Māori Educational Research) and  ‘Te Tohu Rapuora Award (Māori Health Research Excellence).

Dimie Ogoina
MBBS. FWACP, FMCP-Infectious Diseases, FACP, FIDSA

Dimie Ogoina is a Professor of Medicine and Infectious Diseases and an infectious diseases physician. He was listed in Nature’s top 10 scientists in 2022 and recognized as one of Time's 100 most influential persons in 2023 for his groundbreaking research on mpox and contributions to health equity.  
Michael Marks

Professor of Medicine at London School of Hygiene& Tropical Medicine (LSHTM)

I am Professor of Medicine at LSHTM and an Honorary Consultant in Infectious Diseases at the Hospital for Tropical Diseases, University College London Hospital. My major area of interest has been the epidemiology and control of Treponema pallidum including using next-generation sequencing approaches, evaluating Linezolid as a new oral therapy for syphilis investigating integrating near-patient diagnostics for STIs into antenatal care in Zimbabwe.  

Rena Janamnuaysook

Institute of HIV Research and Innovation (IHRI), Thailand 

Rena Janamnuaysook is a Program Manager for Implementation Science at the Institute of HIV Research and Innovation (IHRI) in Bangkok, Thailand, where she co-established Tangerine Clinic as the first transgender-led clinic in the region. She manages and provides technical guidance for the development and implementation of HIV research and programs for key populations in Thailand and in Asia. 

David Koelle

Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington USA

David Koelle is Professor of Medicine at the University of Washington in Seattle. He has focused on HSV local and systemic T cell immunity, genomics, and vaccines, with excursions into other human pathogens including T. pallidum. He will summarize recent findings about the diversity of sexually transmissible agents within the global virome.   

Troy Grennan

Physician lead for the Provincial HIV/STI Program at BCCDC

Dr. Troy Grennan an infectious diseases physician and researcher in Vancouver, Canada, whose work focuses on HIV/STI treatment and prevention, and LGBTQ+ health. Dr. Grennan is Vice-Chair of the Public Health Agency of Canada’s National Advisory Committee on STI, and Co-Principal Investigator of the DISCO study, a Canadian clinical trial examining of doxyPEP and doxyPrEP. 

"An interpretation of the layers of occupation of First Nations People (Gumbaynggirr/Bundjalung Naions) and their symbiotic relationship with flora and fauna on the mighty Clarence River"
Artwork: "Bindarray"
- River by Deborah Taylor 

We acknowledge that the conference is being held the traditional lands of the Gadigal people of the Eora Nation. We recognise Aboriginal and Torres Strait Islander peoples' continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.